Brief: Galapagos CFO, COO Thad Huston To Leave Company on August 1
April 15 (Reuters) - Galapagos NV GLPG.AS: ANNOUNCES DEPARTURE OF THAD HUSTON, CFO AND COO, AS OF AUGUST 1, 2025 Source text: ID:nGNE6bjZYD Further company coverage: GLPG.AS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Lakefront Biotherapeutics NV
See all newsBrief: Lakefront Announces Sale Of Preclinical Car-T Programs To Armed Cell Therapeutics
RBC upgrades Lakefront Biotherapeutics to 'outperform' on gamgertamig prospect
Brief: U.S. FDA Grants Orphan Drug Designation To Gamgertamig For The Treatment Of Pemphigus
Brief: Lakefront Biotherapeutics H1 Net Profit From Continuing Operations €15.8 Mln
Brief: Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline